Platelet cytochrome c oxidase activity and quantity in septic patients

Critical Care Medicine

Volumn 39, Issue 6, 2011, Pages 1289-1294

  Lorente, Leonardo ^a   Martín, María M ^b   López Gallardo, Esther ^c   Iceta, Ruth ^c   Solé Violán, Jordi ^d   Blanquer, José ^e   Labarta, Lorenzo ^f   Díaz, César ^g   Jiménez, Alejandro ^a   Lafuente, Noelia ^a   Hernández, Miriram ^a   Méndez, Froilán ^b   Medina, Nuria ^b   Ferrer Agüero, José M ^d   Ferreres, José ^e   Llimiñana, Maria C ^f   Mora, María L ^a   Lubillo, Santiago ^b   Sánchez Palacios, Manuel ^g   Montoya, Julio ^c   Ruiz Pesini, Eduardo ^c,h   more..

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^b HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^c UNIVERSITY OF ZARAGOZA   (Spain)

^d HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^e HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^f HOSPITAL SAN JORGE   (Spain)

^g HOSPITAL UNIVERSITARIO INSULAR DE GRAN CANARIA   (Spain)

^h Fundación Agencia Aragonesa Para la Investigación y Desarrollo   (Spain)

Author keywords

cytochrome c oxidase; mitochondria; mortality; oxidative phosphorylation; sepsis

Indexed keywords

BILIRUBIN; CITRATE SYNTHASE; CREATININE; CYTOCHROME C OXIDASE; LACTIC ACID;

ADULT; AREA UNDER THE CURVE; ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD PRESSURE; CORRELATIONAL STUDY; CREATININE BLOOD LEVEL; ENZYME ACTIVITY; FEMALE; HUMAN; INTENSIVE CARE UNIT; INTERNATIONAL NORMALIZED RATIO; LACTATE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OXYGEN TENSION; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; SCORING SYSTEM; SEPSIS; SURVIVAL TIME; SURVIVOR; THROMBOCYTE; THROMBOCYTE COUNT;

EID: 79957653128     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31820ee20c     Document Type: Article

References (45)

1. Vincent JL, Sakr Y, Sprung CL, et al: Sepsis in European intensive care units: Results of the SOAP study. Crit Care Med 2006; 34: 344-353. (Pubitemid 43145611)
2. Angus DC, Linde-Zwirble WT, Lidicker J, et al: Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29:1303-1310. (Pubitemid 32641789)
3. Boekstegers P, Weidenhö fer S, Pilz G, et al: Peripheral oxygen availability within skeletal muscle in sepsis and septic shock: Comparison to limited infection and cardiogenic shock. Infection 1991; 19:317-323.
4. Sair M, Etherington PJ, Peter Winlove C, et al: Tissue oxygenation and perfusion in patients with systemic sepsis. Crit Care Med 2001; 29:1343-1349. (Pubitemid 32641795)
5. Hayes MA, Timmins AC, Yau EH, et al: Oxygen transport patterns in patients with sepsis syndrome or septic shock: Influence of treatment and relationship to outcome. Crit Care Med 1997; 25:926-936. (Pubitemid 27264235)
6. Fink M: Cytopathic hypoxia in sepsis. Acta Anaesthesiol Scand Suppl 1997; 110:87-95.
7. Brealey D, Brand M, Hargreaves I, et al: Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 2002; 360:219-223. (Pubitemid 34804650)
8. Baudouin SV, Saunders D, Tiangyou W, et al: Mitochondrial DNA and survival after sepsis: A prospective study. Lancet 2005; 366: 2118-2121. (Pubitemid 41797646)
9. Levy MM, Fink MP, Marshall JC, et al: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 2003; 29:530-538. (Pubitemid 36523666)
10. Vincent JL, Moreno R, Takala J, et al: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/ failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996; 22:707-710.
11. Chomyn A: Platelet-mediated transformation of human mitochondrial DNA-less cells. Methods Enzymol 1996; 264:334-339. (Pubitemid 26089321)
12. Faloona GR, Srere PA: Escherichia coli citrate synthase. Purification and the effect of potassium on some properties. Biochemistry 1969; 8:4497-4503.
13. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of proteindye binding. Anal Biochem 1976; 72: 248-254.
14. Kleinbaum DG, Kupper LL, Muller KE, et al: Straight-line regression analysis. In: Applied Regression Analysis and Other Multivariable Methods. Third Edition. Boston, MA, Duxbury Press, 1998, pp 39-87.
15. Marecaux G, Pinsky MR, Dupont E, et al: Blood lactate levels are better prognostic indicators than TNF and IL-6 levels in patients with septic shock. Intensive Care Med 1996; 22:404-408. (Pubitemid 26174310)
16. Phua J, Koay ES, Lee KH: Lactate, procalcitonin, and amino-terminal pro-B-type natriuretic peptide versus cytokine measurements and clinical severity scores for prognostication in septic shock. Shock 2008; 29: 328-333. (Pubitemid 351271703)
17. Kapsa RM, Quigley AF, Han TF, et al: mtDNA replicative potential remains constant during ageing: polymerase gamma activity does not correlate with age related cytochrome oxidase activity decline in platelets. Nucleic Acids Res 1998; 26:4365-4373. (Pubitemid 28442126)
18. Mancuso M, Filosto M, Bosetti F, et al: Decreased platelet cytochrome c oxidase activity is accompanied by increased blood lactate concentration during exercise in patients with Alzheimer disease. Exp Neurol 2003; 182:421-426. (Pubitemid 36937094)
19. Tomasiak M, Stelmach H, Rusak T, et al: Nitric oxide and platelet energy metabolism. Acta Biochim Pol 2004; 51:789-803. (Pubitemid 39296931)
20. Rusak T, Tomasiak M, Ciborowski M: Peroxynitrite can affect platelet responses by inhibiting energy production. Acta Biochim Pol 2006; 53:769-776. (Pubitemid 46090125)
21. Smith PR, Cooper JM, Govan GG, et al: Platelet mitochondrial function in Leber's hereditary optic neuropathy. J Neurol Sci 1994; 122:80-83. (Pubitemid 24073754)
22. Herrero-Martín MD, Pineda M, Briones P, et al: A new pathologic mitochondrial DNA mutation in the cytochrome oxidase subunit I (MT-CO1). Hum Mutat 2008; 29:E112-E122.
23. Carré JE, Orban JC, Re L, et al: Survival in critical illness is associated with early activation of mitochondrial biogenesis. Am J Respir Crit Care Med 2010; 182:745-751.
24. Pyle A, Burn DJ, Gordon C, et al: Fall in circulating mononuclear cell mitochondrial DNA content in human sepsis. Intensive Care Med 2010; 36:956-962.
25. Williams RS: Mitochondrial gene expression in mammalian striated muscle. Evidence that variation in gene dosage is the major regulatory event. J Biol Chem 1986; 261: 12390-12394. (Pubitemid 17202812)
26. Suliman HB, Carraway MS, Piantadosi CA: Postlipopolysaccharide oxidative damage of mitochondrial DNA. Am J Respir Crit Care Med 2003; 167:570-579.
27. Suliman HB, Welty-Wolf KE, Carraway M, et al: Lipopolysaccharide induces oxidative cardiac mitochondrial damage and biogenesis. Cardiovasc Res 2004; 64:279-288. (Pubitemid 39361689)
28. Callahan LA, Supinski GS: Sepsis induces diaphragm electron transport chain dysfunction and protein depletion. Am J Respir Crit Care Med 2005; 172:861-868. (Pubitemid 41369070)
29. Suliman HB, Carraway MS, Welty-Wolf KE, et al: Lipopolysaccharide stimulates mitochondrial biogenesis via activation of nuclear respiratory factor-1. J Biol Chem 2003; 278: 41510-41518. (Pubitemid 37280980)
30. Haden DW, Suliman HB, Carraway MS, et al: Mitochondrial biogenesis restores oxidative metabolism during Staphylococcus aureus sepsis. Am J Respir Crit Care Med 2007; 176:768-777. (Pubitemid 47598478)
31. Suliman HB, Welty-Wolf KE, Carraway MS, et al: Toll-like receptor 4 mediates mitochondrial DNA damage and biogenic responses after heat-inactivated E. coli. FASEB J 2005; 19:1531-1533. (Pubitemid 41279021)
32. Wittebole X, Castanares-Zapatero D, Laterre PF: Toll-like receptor 4 modulation as a strategy to treat sepsis. Mediators Inflamm 2010; 568396.
33. Beaulieu LM, Freedman JE: The role of inflammation in regulating platelet production and function: Toll-like receptors in platelets and megakaryocytes. Thromb Res 2010; 125: 205-209.
34. Freishtat RJ, Natale J, Benton AS, et al: Sepsis alters the megakaryocyte-platelet transcriptional axis resulting in granzyme B-mediated lymphotoxicity. Am J Respir Crit Care Med 2009; 179:467-473.
35. Gomez-Duran A, Pacheu-Grau D, Lopez- Gallardo E, et al: Unmasking the causes of multifactorial disorders: OXPHOS differences between mitochondrial haplogroups. Hum Mol Genet 2010; 19:3343-3353.
36. Vincent JL, Yagushi A, Pradier O: Platelet function in sepsis. Crit Care Med 2002; 30: S313-S317. (Pubitemid 34508008)
37. Wei J, Guo H, Kuo PC: Endotoxin-stimulated nitric oxide production inhibits expression of cytochrome c oxidase in ANA-1 murine macrophages. J Immunol 2002; 168:4721-4727. (Pubitemid 34441380)
38. Simonson SG, Welty-Wolf K, Huang YT, et al: Altered mitochondrial redox responses in gram negative septic shock in primates. Circ Shock 1994; 43:34-43. (Pubitemid 24281880)
39. Forget AP, Mangalaboyi J, Mordon S, et al: Escherichia coli endotoxin reduces cytochrome aa3 redox status in pig skeletal muscle. Crit Care Med 2000; 28:3491-3497.
40. Callahan LA, Supinski GS: Downregulation of diaphragm electron transport chain and glycolytic enzyme gene expression in sepsis. J Appl Physiol 2005; 99:1120-1126. (Pubitemid 41214531)
41. Chen HW, Hsu C, Lu TS, et al: Heat shock pretreatment prevents cardiac mitochondrial dysfunction during sepsis. Shock 2003; 20: 274-279.
42. Levy RJ, Vijayasarathy C, Raj NR, et al: Competitive and noncompetitive inhibition of myocardial cytochrome C oxidase in sepsis. Shock 2004; 21:110-114.
43. Verma R, Huang Z, Deutschman CS, et al: Caffeine restores myocardial cytochrome oxidase activity and improves cardiac function during sepsis. Crit Care Med 2009; 37: 1397-1402.
44. Chuang YC, Tsai JL, Chang AY, et al: Dysfunction of the mitochondrial respiratory chain in the rostral ventrolateral medulla during experimental endotoxemia in the rat. J Biomed Sci 2002; 9:542-548. (Pubitemid 35316866)
45. d'Avila JC, Santiago AP, Amâncio RT, et al: Sepsis induces brain mitochondrial dysfunction. Crit Care Med 2008; 36:1925-1932